Početna › KOPB › South Carolina
Kliničke studije za KOPB u državi South Carolina
14 studija za KOPB traži sudionike na lokacijama u državi South Carolina.
Gradovi u državi South Carolina
Službeni tekst studije (engleski)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Anderson
- Research Site, Charleston
- Research Site, Gaffney
- i još 2
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- MedTrial- Site Number : 8400010, Columbia
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Clinical Research of Rock Hill, Rock Hill
U tijeku regrutacijaFaza 2
Od 40 do 85 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- AnMed Oglesby Center- Site Number : 8400074, Anderson
- MD First Research - Lancaster- Site Number : 8400102, Lancaster
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Lancaster
- Research Site, Spartanburg
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Anderson
- Research Site, Columbia
- Research Site, Gaffney
- i još 2
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Rock Hill
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Bogan Sleep Consultants, LLC, Columbia
- Velocity Clinical Research, Gaffney, Gaffney
- Clinical Research of Rock Hill, Rock Hill
- i još 1
U tijeku regrutacijaFaza 2/3
Od 35 do 80 godina · Oba spola · Ažurirano 31. kol 2026. · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 101, Charleston
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 11. kol 2026. · NCT07555483STRIVE Post-Market Registry Study
- AnMed Health, Anderson
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 3. kol 2026. · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Greenville
- GSK Investigational Site, Rock Hill
U tijeku regrutacijaFaza 3
Od 40 do 75 godina · Oba spola · Ažurirano 28. srp 2026. · NCT07177339Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Spartanburg
- GSK Investigational Site, Union
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 9. tra 2026. · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Rock Hill
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 8. lis 2025. · NCT06959095Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Medical University of South Carolina (MUSC), Charleston
- McLeod Health, Florence
U tijeku regrutacijaOpažajna studija
Od 50 godina i više · Oba spola · Ažurirano 5. kol 2025. · NCT06122077Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.